On January 8, 2018, Iridex Corporation (“Plaintiff”) filed a complaint against Quantel Medical, S.A., Quantel USA, Inc., and Quantel, S.A. (“Defendants”) asserting infringement of U.S. Patent No. 7,771,417 (“the ‘417 Patent”). The ‘417 Patent is assigned to the Plaintiff and is drawn to laser technology for the non-invasive treatment of certain diseases of the eye. The Plaintiff is asserting that the Defendants are infringing the asserted patent by selling, offering to sell, and/or importing products that perform methods claimed in the ‘417 Patent, including the SS577 and EasyRet products of the Defendants. The case remains pending and is captioned 3-18-cv-00153.
By: Jackie DiRamio